Herantis Pharma Oyj

HRPMF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$5$0-$9-$13
Dep. & Amort.$0$0$0$3
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$2$0-$0$0
Other Non-Cash-$0-$5$0-$0
Operating Cash Flow-$7-$5-$9-$10
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$2$0$0$0
Inv. Sales/Matur.$1$0$0$0
Other Inv. Act.$0$1-$0$0
Investing Cash Flow-$0$1-$0$0
Financing Activities
Debt Repay.-$0-$0-$0$0
Stock Issued$0$5$9$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$2$0$0$4
Financing Cash Flow$2$4$9$4
Forex Effect$0$0$0$0
Net Chg. in Cash-$5$0-$1-$6
Supplemental Information
Beg. Cash$6$5$6$12
End Cash$1$6$5$6
Free Cash Flow-$7-$5-$9-$10